Argyle Capital Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.21M | Buy |
30,717
+300
| +1% | +$23.1K | 0.72% | 50 |
|
|
2025
Q4 | $2.41M | Hold |
30,417
| – | – | 0.81% | 47 |
|
|
2025
Q3 | $2.29M | Hold |
30,417
| – | – | 0.79% | 45 |
|
|
2025
Q2 | $2.1M | Buy |
30,417
+200
| +0.7% | +$13.1K | 0.76% | 51 |
|
|
2025
Q1 | $2.05M | Buy |
30,217
+900
| +3% | +$53.9K | 0.76% | 51 |
|
|
2024
Q4 | $1.32M | Sell |
29,317
-5,085
| -15% | -$285K | 0.52% | 62 |
|
|
2024
Q3 | $2.16M | Sell |
34,402
-1,600
| -4% | -$93.3K | 0.86% | 49 |
|
|
2024
Q2 | $2.13M | Sell |
36,002
-1,634
| -4% | -$102K | 0.88% | 47 |
|
|
2024
Q1 | $3M | Sell |
37,636
-750
| -2% | -$57.3K | 1.16% | 34 |
|
|
2023
Q4 | $3.03M | Sell |
38,386
-5,925
| -13% | -$422K | 1.26% | 32 |
|
|
2023
Q3 | $3.09M | Buy |
44,311
+3,000
| +7% | +$213K | 1.13% | 33 |
|
|
2023
Q2 | $2.86M | Sell |
41,311
-600
| -1% | -$42.7K | 1.03% | 37 |
|
|
2023
Q1 | $3.11M | Buy |
41,911
+2,700
| +7% | +$226K | 1.09% | 39 |
|
|
2022
Q4 | $3.65M | Sell |
39,211
-125
| -0.3% | -$12.1K | 1.26% | 29 |
|
|
2022
Q3 | $3.75M | Sell |
39,336
-200
| -0.5% | -$19.8K | 1.46% | 21 |
|
|
2022
Q2 | $3.66M | Sell |
39,536
-700
| -2% | -$68.3K | 1.31% | 29 |
|
|
2022
Q1 | $4.07M | Sell |
40,236
-1,085
| -3% | -$114K | 1.33% | 29 |
|
|
2021
Q4 | $4.26M | Sell |
41,321
-750
| -2% | -$69.3K | 1.33% | 31 |
|
|
2021
Q3 | $3.57M | Sell |
42,071
-125
| -0.3% | -$10.5K | 1.18% | 39 |
|
|
2021
Q2 | $3.52M | Sell |
42,196
-25
| -0.1% | -$2.05K | 1.14% | 38 |
|
|
2021
Q1 | $3.18M | Sell |
42,221
-50
| -0.1% | -$3.64K | 1.07% | 41 |
|
|
2020
Q4 | $2.89M | Buy |
42,271
+64
| +0.2% | +$4.16K | 1.07% | 41 |
|
|
2020
Q3 | $2.46M | Sell |
42,207
-741
| -2% | -$46.1K | 1.01% | 42 |
|
|
2020
Q2 | $2.79M | Hold |
42,948
| – | – | 1.17% | 35 |
|
|
2020
Q1 | $2.55M | Sell |
42,948
-75
| -0.2% | -$5.01K | 1.2% | 32 |
|
|
2019
Q4 | $3.2M | Sell |
43,023
-650
| -1% | -$45.6K | 1.13% | 38 |
|
|
2019
Q3 | $2.75M | Sell |
43,673
-200
| -0.5% | -$11.9K | 1.04% | 45 |
|
|
2019
Q2 | $2.39M | Buy |
43,873
+500
| +1% | +$26.9K | 0.91% | 49 |
|
|
2019
Q1 | $2.34M | Hold |
43,373
| – | – | 0.9% | 47 |
|
|
2018
Q4 | $2.84M | Buy |
43,373
+863
| +2% | +$64.4K | 1.2% | 34 |
|
|
2018
Q3 | $3.35M | Hold |
42,510
| – | – | 1.25% | 34 |
|
|
2018
Q2 | $2.74M | Sell |
42,510
-300
| -0.7% | -$19.8K | 1.08% | 39 |
|
|
2018
Q1 | $2.66M | Buy |
42,810
+4,250
| +11% | +$305K | 1.06% | 40 |
|
|
2017
Q4 | $2.8M | Buy |
38,560
+13,550
| +54% | +$985K | 1.05% | 43 |
|
|
2017
Q3 | $2.03M | Buy |
25,010
+4,525
| +22% | +$358K | 0.8% | 51 |
|
|
2017
Q2 | $1.65M | Buy |
20,485
+4,325
| +27% | +$342K | 0.67% | 58 |
|
|
2017
Q1 | $1.27M | Sell |
16,160
-65
| -0.4% | -$5.19K | 0.52% | 66 |
|
|
2016
Q4 | $1.28M | Buy |
16,225
+3,323
| +26% | +$269K | 0.54% | 65 |
|
|
2016
Q3 | $1.15M | Sell |
12,902
-680
| -5% | -$64.2K | 0.5% | 67 |
|
|
2016
Q2 | $1.3M | Hold |
13,582
| – | – | 0.55% | 65 |
|
|
2016
Q1 | $1.41M | Sell |
13,582
-450
| -3% | -$43.8K | 0.64% | 59 |
|
|
2015
Q4 | $1.37M | Hold |
14,032
| – | – | 0.63% | 61 |
|
|
2015
Q3 | $1.35M | Hold |
14,032
| – | – | 0.66% | 61 |
|
|
2015
Q2 | $1.47M | Sell |
14,032
-1,848
| -12% | -$189K | 0.67% | 56 |
|
|
2015
Q1 | $1.64M | Sell |
15,880
-117
| -0.7% | -$11.8K | 0.73% | 55 |
|
|
2014
Q4 | $1.54M | Hold |
15,997
| – | – | 0.68% | 58 |
|
|
2014
Q3 | $1.27M | Sell |
15,997
-2,100
| -12% | -$166K | 0.59% | 61 |
|
|
2014
Q2 | $1.36M | Hold |
18,097
| – | – | 0.64% | 58 |
|
|
2014
Q1 | $1.35M | Sell |
18,097
-400
| -2% | -$28.3K | 0.67% | 56 |
|
|
2013
Q4 | $1.32M | Sell |
18,497
-1,167
| -6% | -$75K | 0.67% | 55 |
|
|
2013
Q3 | $1.12M | Hold |
19,664
| – | – | 0.61% | 56 |
|
|
2013
Q2 | $1.12M | Buy |
+19,664
| New | +$1.14M | 0.64% | 55 |
|
Other funds holding CVS
VCM
VPM
Argyle Capital Management's CVS Position: Q1 2026 in Review
Argyle Capital Management increased its CVS Health (CVS) stake by 0.99% in Q1 2026, buying an estimated $23.1K and bringing the position to 30,717 shares worth $2.21M. The position accounts for 0.72% of the portfolio, ranked #50.
Argyle Capital Management first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.26M in Q4 2021. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Argyle Capital Management held 30,717 shares of CVS Health worth $2.21M as of Q1 2026.
- Argyle Capital Management bought 300 CVS Health shares in Q1 2026, an estimated $23.1K.
- CVS Health made up 0.72% of Argyle Capital Management's portfolio in Q1 2026, its #50 holding.
- Argyle Capital Management first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
- Argyle Capital Management's CVS Health position peaked at $4.26M in Q4 2021.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Argyle Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.